Scinai Immunotherapeutics annual operating expenses
2017
2021
2022
2023
2024
2025
Scinai Immunotherapeutics Operating Expenses Growth & History (SCNI)
Scinai Immunotherapeutics's operating expenses was $4.9M for fiscal 2025.
View full Scinai Immunotherapeutics company overviewScinai Immunotherapeutics annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $4.9M | −$3.2M | −39.31% |
| 2024 | 2024-12-31 | $8.1M | −$1.6M | −16.98% |
| 2023 | 2023-12-31 | $9.7M | −$1.4M | −12.25% |
| 2022 | 2022-12-31 | $11.1M | $199,000 | +1.83% |
| 2021 | 2021-12-31 | $10.9M | — | — |
| 2017 | 2017-12-31 | $6.8M | — | — |
Scinai Immunotherapeutics quarterly operating expenses
Q4.24
Q1.25
Q2.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $894,000 | $197,000 | +28.26% |
| Q1 2026 | 2026-03-31 | $1.3M | −$447,000 | −24.89% |
| Q2 2025 | 2025-06-30 | $697,000 | — | — |
| Q1 2025 | 2025-03-31 | $1.8M | — | — |
| Q4 2024 | 2024-12-31 | $2.1M | — | — |
Scinai Immunotherapeutics operating expenses trends
Between the periods ended 2017-12-31 and 2025-12-31, Scinai Immunotherapeutics's operating expenses decreased from $6.8M to $4.9M, a change of −$1.9M. The latest reported quarter, Q2 2026, shows $894,000.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Scinai Immunotherapeutics source filings ↗